Mark Shaw

2.1k citations
41 papers · 1.3k · 1 hit paper · h-index 17

Impact in

    • Lung Cancer Diagnosis and Treatment
    • Renal cell carcinoma treatment
    • Prostate Cancer Treatment and Research
    • Prostate Cancer Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
  • Radiation top 5%
    • Advanced Radiotherapy Techniques

Papers in

Mark Shaw

38 papers receiving 1.3k citations

Mark Shaw's Hit Papers

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial 2019 · 389 citations
3890+2+4Years since publication100200300

Peers

Mark Shaw
Comparison fields: 5 of 76
  • Pulmonary and Respiratory Medicine 757
  • Radiation 207
  • Radiology, Nuclear Medicine and Imaging 276
  • Ecological Modeling 50
  • Oncology 156
Replace Michèle Tarayre with:
Michèle Tarayre France
Clare Griffin United Kingdom
Magnus Hellström Sweden
H Nishikawa Japan
Michelle E. St. John United States
Scott Fisher Australia
Christine Berger France
Michael W. Nolan United States
Éric Levy United States
Anders Traberg Hansen Denmark
Mark Shaw relative to Michèle Tarayre France Michèle Tarayre's profile →
Citations per field
00.5×4.5×
Michèle Tarayre · 1×
Citations per year

Countries citing papers authored by Mark Shaw

Since Specialization
Citations

This map shows the geographic impact of Mark Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shaw more than expected).

Fields of papers citing papers by Mark Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shaw. The network helps show where Mark Shaw may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Shaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Shaw Line = papers co-authored together Mark Shaw links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial
Hit paper breakdown →
2019389
2 2018231
3 202190
4 201786
5 201471
6 201660
7 201547
8 201842
9 202237
10 201335
11 201534
12 201332
13 201726
14 202025
15
A geographic analysis of the status of mountain lions in Oklahoma
199920
16 201816
17 201716
18 201912
19 20218
20 20237

About Mark Shaw

Mark Shaw is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Radiology, Nuclear Medicine and Imaging and Ecological Modeling, having authored 41 papers that have together received 1.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Lung Cancer Diagnosis and Treatment (8 papers), Species Distribution and Climate Change (4 papers), Management of metastatic bone disease (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers), MRI in cancer diagnosis (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (757 citations), Radiation (207 citations), Radiology, Nuclear Medicine and Imaging (276 citations), Ecological Modeling (50 citations) and Oncology (156 citations). Mark Shaw has collaborated with scholars based in Australia, United Kingdom and New Zealand. Frequent co-authors include Tomas Kron, Shankar Siva, David Ball, Mathias Bressel, Sarat Chander, Nathan Lawrentschuk, Farshad Foroudi, Brent Chesson, Declan G. Murphy and Michael S. Hofman. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology and Radiation Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact